March 21, 2024
Innate Pharma Halts Phase 1b Trial for Peripheral T Cell Lymphoma Treatment Amidst NextCure Layoff Announcement
Innate Pharma, Peripheral T Cell Lymphoma, Phase 1b Trial Termination, NextCure Layoffs
Orchard Therapeutics Sets $4.25 Million Price Tag for Leukodystrophy Gene Therapy
Orchard Therapeutics, Leukodystropy, Gene Therapy, Lenmeldy, $4.25 million US price tag